Cargando…
Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatment
BACKGROUND: Pro-oxidant drugs have been proposed for treating certain cancers but the resistance developed by cancer cells to oxidative stress limits its potential use in clinics. To understand the mechanisms underlying resistance to oxidative stress, we found that the chronic exposure to an H(2)O(2...
Autores principales: | Glorieux, Christophe, Calderon, Pedro Buc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819285/ https://www.ncbi.nlm.nih.gov/pubmed/29467594 http://dx.doi.org/10.1186/s12935-018-0524-0 |
Ejemplares similares
-
Evaluation of Potential Mechanisms Controlling the Catalase Expression in Breast Cancer Cells
por: Glorieux, Christophe, et al.
Publicado: (2018) -
Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
por: Glorieux, Christophe, et al.
Publicado: (2019) -
Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
por: Hu, Jiasheng, et al.
Publicado: (2013) -
Targeting Catalase but Not Peroxiredoxins Enhances Arsenic Trioxide-Induced Apoptosis in K562 Cells
por: Song, Li-Li, et al.
Publicado: (2014) -
Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms
por: Yu, Guifang, et al.
Publicado: (2015)